These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20621692)

  • 1. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure.
    Kleinbongard P; Heusch G; Schulz R
    Pharmacol Ther; 2010 Sep; 127(3):295-314. PubMed ID: 20621692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha.
    Xu Y; Arenas IA; Armstrong SJ; Plahta WC; Xu H; Davidge ST
    Cardiovasc Res; 2006 Mar; 69(4):836-44. PubMed ID: 16403479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFalpha in ischemia/reperfusion injury and heart failure.
    Schulz R; Aker S; Belosjorow S; Heusch G
    Basic Res Cardiol; 2004 Jan; 99(1):8-11. PubMed ID: 14685700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning.
    Deuchar GA; Opie LH; Lecour S
    Life Sci; 2007 Apr; 80(18):1686-91. PubMed ID: 17316703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.
    Mihov D; Bogdanov N; Grenacher B; Gassmann M; Zünd G; Bogdanova A; Tavakoli R
    Eur J Cardiothorac Surg; 2009 May; 35(5):839-46; discussion 846. PubMed ID: 19237290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.
    Kleinbongard P; Schulz R; Heusch G
    Heart Fail Rev; 2011 Jan; 16(1):49-69. PubMed ID: 20571888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications.
    von Haehling S; Jankowska EA; Anker SD
    Basic Res Cardiol; 2004 Jan; 99(1):18-28. PubMed ID: 14685702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelial function in coronary atherosclerosis and heart failure--the role of nitric oxide in regulation of vasomotor tone].
    Andreassen AK; Kirkebøen KA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4066-9. PubMed ID: 10613099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery endothelial function after myocardial ischemia and reperfusion.
    Seccombe JF; Schaff HV
    Ann Thorac Surg; 1995 Sep; 60(3):778-88. PubMed ID: 7545892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury.
    Gao X; Xu X; Belmadani S; Park Y; Tang Z; Feldman AM; Chilian WM; Zhang C
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1269-75. PubMed ID: 17413034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
    Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
    Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart.
    Aleshin A; Sawa Y; Ono M; Funatsu T; Miyagawa S; Matsuda H
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):974-80. PubMed ID: 15519192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?
    Lecour S
    J Mol Cell Cardiol; 2009 Jul; 47(1):32-40. PubMed ID: 19344728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: role of Akt-stimulated NO production.
    Ma H; Zhang HF; Yu L; Zhang QJ; Li J; Huo JH; Li X; Guo WY; Wang HC; Gao F
    Cardiovasc Res; 2006 Jan; 69(1):57-65. PubMed ID: 16212952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between expression of TNF alpha, iNOS, VEGF mRNA and development of heart failure after experimental myocardial infarction in rats.
    Heba G; Krzemiński T; Porc M; Grzyb J; Dembińska-Kieć A
    J Physiol Pharmacol; 2001 Mar; 52(1):39-52. PubMed ID: 11321512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of insulin on cardiac function and coronary circulation in acute myocardial ischemia and reperfusion experiment with dogs].
    Ma H; Huo JH; Zhang HX; Bian JF; Wang YM; Xiong LZ; Guo WY; Wang HC; Gao F
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3128-32. PubMed ID: 17313765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
    du Toit EF; Nabben M; Lochner A
    Basic Res Cardiol; 2005 Jul; 100(4):346-54. PubMed ID: 15821998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium, ischemia and the good side of oxygen free radicals.
    Grotti S; Gori T
    Clin Hemorheol Microcirc; 2008; 39(1-4):197-203. PubMed ID: 18503126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusion.
    Lefer DJ
    New Horiz; 1995 Feb; 3(1):105-12. PubMed ID: 7704591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.